Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for Seres Therapeutics Inc have a median target of 1.25, with a high estimate of 10.00 and a low estimate of 1.00. The median estimate represents a 70.81% increase from the last price of 0.7318.
High | 1,266.5% | 10.00 |
Med | 70.8% | 1.25 |
Low | 36.6% | 1.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | -6.27% |
Average growth rate | -28.49% |
More ▼
Revenue history & estimates in USD
Average growth rate | -44.84% |
Average growth rate | +477.44% |
More ▼